Capricor Therapeutics Inc Capital Reinvestment Ratio
Capricor Therapeutics Inc capital reinvestment ratio. Capricor Therapeutics Inc (CAPR) has a Capital Reinvestment Ratio of 0.11x as of March 2023, meaning it reinvests 0% of its operating cash flow ($4.21 Million) in capital expenditures ($453.12K). Check total reinvestment intensity of Capricor Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Capricor Therapeutics Inc (2014–2022)
Capital reinvestment ratio of Capricor Therapeutics Inc from 2014 to 2022. This chart tracks Capricor Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore Capricor Therapeutics Inc (CAPR) net asset momentum to track the company's year-over-year net asset growth rate.
Capricor Therapeutics Inc Capital Reinvestment Ratio by Year (2014–2022)
Capricor Therapeutics Inc capital reinvestment ratio by year from 2014 to 2022. For the full cash flow conversion analysis, see cash efficiency ratio of Capricor Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.68x | $4.92 Million | $3.36 Million | ▲ +251.3% |
| 2014 | 0.19x | $958.56K | $186.43K | — |